AP — 01
GIPGLP-1
Tirzepatide
Dual GIP / GLP-1 receptor agonist
RUO
A synthetic peptide studied for its dual activity at glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.
Research focus
- Incretin receptor signaling
- Glucose and metabolic pathway research
- Energy-balance and body-weight mechanisms
For laboratory research only. Not for human consumption.
AP — 02
GIPGLP-1GCG
Retatrutide
Investigational GLP-1 / GIP / glucagon receptor agonist
RUO
An investigational peptide designed to activate GIP, GLP-1, and glucagon receptors within a single molecule. It remains investigational and is not FDA-approved.
Research focus
- Triple-receptor signaling
- Metabolic and energy-expenditure pathways
- Preclinical and clinical mechanism research
For laboratory research only. Not for human consumption.
AP — 03
KLOW
KLOW (Advanced Wolverine Stack)
Multi-component research blend
RUO
A research blend commonly described as containing GHK-Cu, BPC-157, TB-500, and KPV. Published evidence relates primarily to the individual components rather than the combined blend.
Component research areas
- Cellular signaling and tissue-model research
- Inflammatory-pathway investigation
- Extracellular-matrix and repair-model studies
Blend-level effects are not established. Research use only.
AP — 04
GHKCu
GHK-Cu
Copper-binding tripeptide complex
RUO
A naturally occurring GHK peptide complexed with copper, widely investigated in cellular and tissue models involving extracellular matrix, fibroblast activity, and remodeling pathways.
Research focus
- Fibroblast and extracellular-matrix activity
- Collagen-related cellular pathways
- Tissue-remodeling model research
For laboratory research only. Not for human consumption.
AP — 05
CJCIPA
CJC-1295 / Ipamorelin
Growth-hormone-axis research pairing
RUO
A research pairing of a growth hormone-releasing hormone analog (CJC-1295) and a ghrelin-receptor growth hormone secretagogue (Ipamorelin), studied around complementary GH-axis signaling. Combination-specific clinical evidence is limited.
Research focus
- GHRH and growth-hormone secretagogue signaling
- GH / IGF-1 endocrine-axis models
- Peptide interaction and secretion-pathway research
Investigational research materials. Not for human consumption.
AP — 06
MTC
MOTS-C
Mitochondrial-derived peptide
RUO
A mitochondrial-derived peptide studied as a signaling molecule in cellular responses to metabolic stress and in communication between mitochondrial function and broader cellular pathways.
Research focus
- Mitochondrial retrograde signaling
- Metabolic-stress and AMPK-associated pathways
- Cellular energy-homeostasis models
For laboratory research only. Not for human consumption.
AP — 07
NAD+
NAD+
Cellular redox coenzyme
RUO
Nicotinamide adenine dinucleotide (NAD+) is an essential cellular coenzyme and signaling substrate central to redox reactions, bioenergetics, and multiple NAD+-dependent enzyme systems.
Research focus
- Cellular redox and bioenergetic pathways
- Sirtuin, PARP, and CD38-associated signaling
- DNA-repair and cellular-stress research
For laboratory research only. Not for human consumption.
AP — 08
GHRFTES
Tesamorelin
Growth hormone-releasing factor analog
RUO
A synthetic analog of growth hormone-releasing factor (GHRF) that is studied for its activity at the GHRH receptor and downstream GH / IGF-1 signaling. Tesamorelin is also the active ingredient in an FDA-approved prescription drug for a specific indication; Ace Peptides material is presented solely as research use only.
Research focus
- GHRH receptor and pituitary signaling
- GH / IGF-1 endocrine-axis research
- Adipose-tissue and metabolic-pathway models
Research material only. Not an approved Ace Peptides drug product.
Research context matters.
Descriptions refer to areas studied in scientific literature and ongoing investigation. They do not establish safety, efficacy, dosing, or clinical utility for Ace Peptides research materials.